Academia.edu no longer supports Internet Explorer.
To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.
Suicide is a global phenomenon in all regions of the world affecting people of all age groups. It has detrimental consequences on patients, their families, and the community as a whole. There have been numerous risk factors described for suicide including mental illness, stressful life situations, loss of social support, and general despair. The association of suicide with Islam has not been extensively studied. The common impression from clinical practice is that being a practicing Muslim reduces the risk of suicide. Another factor associated with suicide is starting a patient on antidepressants. However, this has been questioned recently. This report describes a middle-aged man with depression and multiple social stressors who survived a serious suicide attempt. The discussion will focus on the factors that lead him to want to end his life and the impact of the assumed protective factors such as religious belief and family support on this act of selfharm. Such patients can be on the edge when there is an imbalance between risk factors (such as depression, insomnia, and psychosocial stressors) and protective factors (like religious affiliation and family support). All physicians are advised to assess the suicide risk thoroughly in patients with depression regardless of any presumed protective factor.
Psychiatry (Edgmont (Pa. : Township))
Adolescent depression: an update and guide to clinical decision making2009 •
Depression in adolescence and adulthood is common, afflicting up to 20 percent of these populations. It represents a significant public health concern and is associated with considerable suffering and functional impairment. Adolescent-onset depression tends to be a particularly malignant and recalcitrant condition, increasing the likelihood of recurrence and chronicity in adulthood. Clinical presentations for various medical and psychiatric conditions, as well as reactions to psychosocial stressors, can mimic or confound the picture of depression in adolescents. Therefore, careful assessment and differential diagnosis is essential. Effective treatments, both pharmacological and psychosocial in nature, exist, and so early detection and intervention is paramount. This article presents an overview of optimal prevention, assessment, and clinical decision-making strategies for managing depression in adolescents.
Journal of the American Academy of Child & Adolescent Psychiatry
Practice Parameter for the Assessment and Treatment of Youth in Juvenile Detention and Correctional Facilities2005 •
This parameter reviews the current status of reactive attachment disorder with regard to assessment and treatment. Attachment is a central component of social and emotional development in early childhood, and disordered attachment is defined by specific patterns of abnormal social behavior in the context of "pathogenic care." Clinically relevant subtypes include an emotionally withdrawn/inhibited pattern and a socially indiscriminate/disinhibited pattern. Assessment requires direct observation of the child in the context of his/her relationships with primary caregivers. Treatment requires establishing an attachment relationship for the child when none exists and ameliorating disturbed attachment relationships with caregivers when they are evident. Coercive treatments with children with attachment disorders are potentially dangerous and not recommended.
European Psychiatry
EPA guidance on suicide preventionSuicide is a major public health problem in the WHO European Region accounting for over 150,000 deaths per year.Acute intervention should start immediately in order to keep the patient alive.An underlying psychiatric disorder is present in up to 90% of people who completed suicide. Comorbidity with depression, anxiety, substance abuse and personality disorders is high. In order to achieve successful prevention of suicidality, adequate diagnostic procedures and appropriate treatment for the underlying disorder are essential.Existing evidence supports the efficacy of pharmacological treatment and cognitive behavioural therapy (CBT) in preventing suicidal behaviour. Some other psychological treatments are promising, but the supporting evidence is currently insufficient. Studies show that antidepressant treatment decreases the risk for suicidality among depressed patients. However, the risk of suicidal behaviour in depressed patients treated with antidepressants exists during the first 10–14 days of treatment, which requires careful monitoring. Short-term supplementary medication with anxiolytics and hypnotics in the case of anxiety and insomnia is recommended. Treatment with antidepressants of children and adolescents should only be given under supervision of a specialist. Long-term treatment with lithium has been shown to be effective in preventing both suicide and attempted suicide in patients with unipolar and bipolar depression. Treatment with clozapine is effective in reducing suicidal behaviour in patients with schizophrenia. Other atypical antipsychotics are promising but more evidence is required.Multidisciplinary treatment teams including psychiatrist and other professionals such as psychologist, social worker, and occupational therapist are always preferable, as integration of pharmacological, psychological and social rehabilitation is recommended especially for patients with chronic suicidality.The suicidal person independently of age should always be motivated to involve family in the treatment.Psychosocial treatment and support is recommended, as the majority of suicidal patients have problems with relationships, work, school and lack functioning social networks.A secure home, public and hospital environment, without access to suicidal means is a necessary strategy in suicide prevention. Each treatment option, prescription of medication and discharge of the patient from hospital should be carefully evaluated against the involved risks.Training of general practitioners (GPs) is effective in the prevention of suicide. It improves treatment of depression and anxiety, quality of the provided care and attitudes towards suicide. Continuous training including discussions about ethical and legal issues is necessary for psychiatrists and other mental health professionals.
Neuropsychopharmacologia Hungarica a Magyar Pszichofarmakologiai Egyesulet Lapja Official Journal of the Hungarian Association of Psychopharmacology
[The European Psychiatric Association (EPA) guidance on suicide treatment and prevention]2012 •
Journal of The American Academy of Child and Adolescent Psychiatry
Practice Parameters for the Assessment and Treatment of Children and Adolescents Who Are Sexually Abusive of Others1999 •
Journal of The American Academy of Child and Adolescent Psychiatry
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Schizophrenia2001 •
Journal of The American Academy of Child and Adolescent Psychiatry
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Posttraumatic Stress Disorder2010 •
Journal of The American Academy of Child and Adolescent Psychiatry
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Enuresis2004 •
Journal of The American Academy of Child and Adolescent Psychiatry
Practice Parameters for the Assessment and Treatment of Children, Adolescents, and Adults With Attention-Deficit/Hyperactivity Disorder1997 •
Pharmaceuticals
Antidepressants and Suicide Risk: A Comprehensive Overview2010 •
2010 •
Journal of The American Academy of Child and Adolescent Psychiatry
Practice Parameter for the Assessment and Treatment of Children and Adolescents with Obsessive-Compulsive DisorderThe Journal of Clinical Psychiatry
Suicidal Ideation and Attempts Among Psychiatric Patients With Major Depressive Disorder2003 •
The Journal of Clinical Psychiatry
Suicidal Events in the Treatment for Adolescents With Depression Study (TADS)2009 •
Journal of affective …
Psychotherapeutic intervention and suicide risk reduction in bipolar disorder: a review of the evidence2009 •
Archives of Depression and Anxiety
Depressive disorders: definitions, contexts, differential diagnosis, neural correlates and clinical strategies2019 •
Revista De Neuro Psiquiatria
Suicidal behavior: Risk and protective factors2014 •
Neuropsychiatric Disease and Treatment
Suicide risk in depression and bipolar disorder: Do impulsiveness-aggressiveness and pharmacotherapy predict suicidal intent?2008 •
Journal of affective disorders
Risk factors for suicide in bipolar disorder: a systematic review2015 •
Indian Journal of Psychiatry
Life events, social support, coping strategies, and quality of life in attempted suicide: A case‑control study2013 •
Indian journal of social psychiatry
Marital Commitment and Marital Quality in Spouses of Patients with Psychiatric Disorders2010 •
Journal of Mental Health and Human Behaviour 2013; 18: 9–17.
A longitudinal study of change in prevalence of metabolic syndrome and metabolic disturbances 3 months after clozapine therapyTopics in emergency medicine
Suicide Assessment in Hospital Emergency Departments: Implications for Patient Satisfaction and Compliance2005 •
The International Journal of Neuropsychopharmacology
Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence2007 •
Turk psikiyatri dergisi = Turkish journal of psychiatry
Comparison of parents of children who are cochlear implant candidates with the parents whose children had cochlear implants in terms of mental health and marital satisfactionJournal of the American Academy of Child & Adolescent Psychiatry
Youth Suicide Risk and Preventive Interventions: A Review of the Past 10 Years2003 •
European psychiatry
.Prevalence of hoarding in adolescents with high functioning autism2018 •
Anales de Psicología
Prevention, assessment and treatment of suicidal behavior. [Prevención, evaluación y tratamiento de la conducta suicida]2014 •
2005 •